Is it dexfenfluramine or weight loss that reduces blood pressure and noradrenergic activity in obese patients?

Effect of dexfenfluramine treatment on b

Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients

✍ J. Kolanowski; L. T. Younis; R. Vanbutsele; J. -M. Detry 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 839 KB

The effect of dexfenfluramine (dF) on body weight, blood pressure and noradrenergic activity were studied in 30 obese hypertensive patients randomly divided into two groups and treated for 3 months either with dF (30 mg daily; 16 subjects) or placebo (Pl; 14 subjects). 11 patients from the dF group